登录 注册 会员服务 联系我们

Small Molecules Which Improve Pathogenesis of Myotonic Dystrophy Type 1

  • Published:2018-05-18 Issue: Volume:9 Page:
  • ISSN:1664-2295
  • Container-title:Frontiers in Neurology
  • language:
  • Short-container-title:Front. Neurol.

Author:

López-Morató Marta,Brook John David,Wojciechowska Marzena

Funder

Wellcome Trust

Muscular Dystrophy UK

FP7 People: Marie-Curie Actions

Publisher

Frontiers Media SA

Subject

Clinical Neurology,Neurology

Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy;International Journal of Molecular Sciences;2023-06-26

2. MBNL‐dependent impaired development within the neuromuscular system in myotonic dystrophy type 1;Neuropathology and Applied Neurobiology;2023-01-17

3. Types of neuromuscular disease;Pulmonary Assessment and Management of Patients with Pediatric Neuromuscular Disease;2023

4. Peptide-Conjugated PMOs for the Treatment of Myotonic Dystrophy;Methods in Molecular Biology;2022-11-19

5. Selective Chemical Modification to the Higher‐Order Structures of Nucleic Acids;The Chemical Record;2022-09-16
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3